1. Home
  2. SLNO vs NBTB Comparison

SLNO vs NBTB Comparison

Compare SLNO & NBTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLNO
  • NBTB
  • Stock Information
  • Founded
  • SLNO 1999
  • NBTB 1856
  • Country
  • SLNO United States
  • NBTB United States
  • Employees
  • SLNO N/A
  • NBTB N/A
  • Industry
  • SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • NBTB Major Banks
  • Sector
  • SLNO Health Care
  • NBTB Finance
  • Exchange
  • SLNO Nasdaq
  • NBTB Nasdaq
  • Market Cap
  • SLNO 1.9B
  • NBTB 2.2B
  • IPO Year
  • SLNO 2014
  • NBTB N/A
  • Fundamental
  • Price
  • SLNO $49.17
  • NBTB $48.67
  • Analyst Decision
  • SLNO Strong Buy
  • NBTB Buy
  • Analyst Count
  • SLNO 6
  • NBTB 5
  • Target Price
  • SLNO $74.83
  • NBTB $48.80
  • AVG Volume (30 Days)
  • SLNO 567.7K
  • NBTB 274.9K
  • Earning Date
  • SLNO 03-05-2025
  • NBTB 01-27-2025
  • Dividend Yield
  • SLNO N/A
  • NBTB 2.78%
  • EPS Growth
  • SLNO N/A
  • NBTB 0.14
  • EPS
  • SLNO N/A
  • NBTB 2.85
  • Revenue
  • SLNO N/A
  • NBTB $538,802,000.00
  • Revenue This Year
  • SLNO N/A
  • NBTB N/A
  • Revenue Next Year
  • SLNO N/A
  • NBTB $17.27
  • P/E Ratio
  • SLNO N/A
  • NBTB $16.78
  • Revenue Growth
  • SLNO N/A
  • NBTB 10.23
  • 52 Week Low
  • SLNO $36.61
  • NBTB $32.79
  • 52 Week High
  • SLNO $60.92
  • NBTB $52.44
  • Technical
  • Relative Strength Index (RSI)
  • SLNO 56.57
  • NBTB 53.94
  • Support Level
  • SLNO $45.44
  • NBTB $44.78
  • Resistance Level
  • SLNO $49.03
  • NBTB $48.49
  • Average True Range (ATR)
  • SLNO 2.36
  • NBTB 1.28
  • MACD
  • SLNO 0.66
  • NBTB 0.14
  • Stochastic Oscillator
  • SLNO 98.40
  • NBTB 94.77

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet for the treatment of Prader-Willi Syndrome. DCCR tablets consist of the active ingredient diazoxide choline, a choline salt of diazoxide, which is a benzothiadiazine.

About NBTB NBT Bancorp Inc.

NBT Bancorp Inc is a financial holding company that operates through its subsidiaries. The company's principal sources of revenue include management fees and dividends it receives through its subsidiaries. NBT Bank is a full-service community bank offering a full range of retail and commercial banking products and trust and investment services. Loan products include consumer, home equity, mortgage, business banking, and commercial loans. Nearly half of its loan portfolio is in commercial loans. The bank serves individuals, corporations, and municipalities, and operates scores of locations throughout New York, Pennsylvania, Vermont, Massachusetts, New Hampshire, and Maine.

Share on Social Networks: